UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

The Lancet (British edition), 2010-03, Vol.375 (9717), p.816-823

2010

Volltextzugriff (PDF)

Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas

The Journal of pathology, 2020-03, Vol.250 (3), p.312-322

2020

Volltextzugriff (PDF)

Linking uterine serous carcinoma to BRCA1/2 -associated cancer syndrome: A meta-analysis and case report

European journal of cancer (1990), 2017-02, Vol.72, p.215-225

2017

Volltextzugriff (PDF)

Causality and functional relevance of BRCA1 and BRCA2 pathogenic variants in non-high-grade serous ovarian carcinomas

The Journal of pathology, 2024-02, Vol.262 (2), p.137-146

2024

Volltextzugriff (PDF)

Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer

International journal of cancer, 2012-07, Vol.131 (2), p.E74-E85

2012

Volltextzugriff (PDF)

The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis

Breast cancer research and treatment, 2015-02, Vol.149 (3), p.587-596

2015

Volltextzugriff (PDF)

The Diagnostic Value of One-Step Nucleic acid Amplification (OSNA) for Sentinel Lymph Nodes in Colon Cancer Patients

Annals of surgical oncology, 2014-11, Vol.21 (12), p.3924-3930

2014

Volltextzugriff (PDF)

Postoperative radiotherapy for Stage 1 endometrial carcinoma: Long-term outcome of the randomized PORTEC trial with central pathology review

International journal of radiation oncology, biology, physics, 2005-11, Vol.63 (3), p.834-838

2005

Volltextzugriff (PDF)

EP973 ‘Tumour First’: an institutional experience of reflex tumour BRCA testing in ovarian epithelial carcinomas

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A516-A516

2019

Volltextzugriff (PDF)

Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach

Breast cancer research and treatment, 2015-07, Vol.152 (2), p.247-252

2015

Volltextzugriff (PDF)

Prognostic relevance of the molecular classification in high-risk endometrial cancer: analysis of the PORTEC-3 trial

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A7-A8

2019

Volltextzugriff (PDF)

Abstract P3-07-54: Insulin-like growth factor 1 receptor expression and polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: Results from the NEOZOTAC trial (BOOG 2010-01)

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P3-P3-07-54

2016

Volltextzugriff (PDF)

Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma

Cancer, 2004-02, Vol.100 (4), p.764-772

2004

Volltextzugriff (PDF)

Pediatric germ cell tumors presenting beyond childhood?

Andrology (Oxford), 2015-01, Vol.3 (1), p.70-77

2015

Volltextzugriff (PDF)

Abstract P1-08-19: Changes in circulating vitamin D levels as a predictor for pathological response to neoadjuvant chemotherapy (NAC) in breast cancer (BC): A Dutch breast cancer trialists group (BOOG) side-study

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P1-P1-08-19

2013

Volltextzugriff (PDF)

Abstract P1-06-04: The predictive value of tumor-stroma ratio for radiological and pathological response to neoadjuvant chemotherapy in breast cancer (BC): A Dutch breast cancer trialists’ group (BOOG) side-study

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P1-P1-06-04

2013

Volltextzugriff (PDF)

Patient with two secondary somatic-type malignancies in a late recurrence of a testicular non-seminoma: illustration of potential and flaw of the cancer stem cell therapy concept

The International journal of developmental biology, 2013, Vol.57 (2-4), p.153-157

2013

Volltextzugriff (PDF)

Abstract OT3-1-03: DIRECT: A phase II/III randomized trial with dietary restriction as an adjunct to neoadjuvant chemotherapy for HER2-negative breast cancer

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.OT3-1-03-OT3-1-03

2013

Volltextzugriff (PDF)

Abstract P4-07-02: Expression of Cell Adhesion Molecules Predicts Prognosis in Early Breast Cancer Patients

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P4-P4-07-02

2010

Volltextzugriff (PDF)

Abstract PD07-06: NEO-ZOTAC: Toxicity data of a phase III randomized trial with NEOadjuvant chemotherapy (TAC) with or without ZOledronic acid (ZA) for patients with HER2-negative large resectable or locally advanced breast cancer (BC)

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.PD07-06-PD07-06

2012

Volltextzugriff (PDF)

Combined E‐cadherin, α‐catenin, and β‐catenin expression is a favorable prognostic factor in endometrial carcinoma

International journal of gynecological cancer, 2006-05, Vol.16 (3), p.1379-1385

2006

Volltextzugriff (PDF)

Nuclear β-catenin is a molecular feature of type I endometrial carcinoma

The Journal of pathology, 2003-11, Vol.201 (3), p.460-465

2003

Volltextzugriff (PDF)

Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer

Genes chromosomes & cancer, 2004-10, Vol.41 (2), p.109-116

2004

Volltextzugriff (PDF)

Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients

British journal of cancer, 2009-02, Vol.100 (3), p.494-500

2009

Volltextzugriff (PDF)

Assessment of serum matrix metalloproteinases MMP-2 and MMP-9 after human liver transplantation: increased serum MMP-9 level in acute rejection

Transplantation, 2004-06, Vol.77 (11), p.1646-1652

2004

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(48)

Sprache

Englisch
(48)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas

Linking uterine serous carcinoma to BRCA1/2 -associated cancer syndrome: A meta-analysis and case report

Causality and functional relevance of BRCA1 and BRCA2 pathogenic variants in non-high-grade serous ovarian carcinomas

Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer

The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis

The Diagnostic Value of One-Step Nucleic acid Amplification (OSNA) for Sentinel Lymph Nodes in Colon Cancer Patients

Postoperative radiotherapy for Stage 1 endometrial carcinoma: Long-term outcome of the randomized PORTEC trial with central pathology review

EP973 ‘Tumour First’: an institutional experience of reflex tumour BRCA testing in ovarian epithelial carcinomas

Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach

Prognostic relevance of the molecular classification in high-risk endometrial cancer: analysis of the PORTEC-3 trial

Abstract P3-07-54: Insulin-like growth factor 1 receptor expression and polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: Results from the NEOZOTAC trial (BOOG 2010-01)

Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma

Pediatric germ cell tumors presenting beyond childhood?

Abstract P1-08-19: Changes in circulating vitamin D levels as a predictor for pathological response to neoadjuvant chemotherapy (NAC) in breast cancer (BC): A Dutch breast cancer trialists group (BOOG) side-study

Abstract P1-06-04: The predictive value of tumor-stroma ratio for radiological and pathological response to neoadjuvant chemotherapy in breast cancer (BC): A Dutch breast cancer trialists’ group (BOOG) side-study

Patient with two secondary somatic-type malignancies in a late recurrence of a testicular non-seminoma: illustration of potential and flaw of the cancer stem cell therapy concept

Abstract OT3-1-03: DIRECT: A phase II/III randomized trial with dietary restriction as an adjunct to neoadjuvant chemotherapy for HER2-negative breast cancer

Abstract P4-07-02: Expression of Cell Adhesion Molecules Predicts Prognosis in Early Breast Cancer Patients

Abstract PD07-06: NEO-ZOTAC: Toxicity data of a phase III randomized trial with NEOadjuvant chemotherapy (TAC) with or without ZOledronic acid (ZA) for patients with HER2-negative large resectable or locally advanced breast cancer (BC)

Combined E‐cadherin, α‐catenin, and β‐catenin expression is a favorable prognostic factor in endometrial carcinoma

Nuclear β-catenin is a molecular feature of type I endometrial carcinoma

Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer

Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients

Assessment of serum matrix metalloproteinases MMP-2 and MMP-9 after human liver transplantation: increased serum MMP-9 level in acute rejection

Suchergebnisse filtern